Finance
History of Botox from toxin to blockbuster medical and beauty treatment
- Botox, the pharmaceutical drug best known for smoothing out wrinkles, took more than a decade to reach its potential.
- Initially found to be a treatment for a tight eyelid condition, doctors started realizing that after treatment with botulinum toxin A, patients came out with “lovely, untroubled expressions.”
- Here’s the history of how Botox went from an understudied toxin to a blockbuster drug used by millions.
- To hear the full story of Botox, subscribe to Business Insider’s podcast “Household Name.”
Mitchell Brin has a license plate that says “Botox.”
Brin’s been researching Botox since 1984 and is currently the chief scientific officer of Botox at the drug company Allergan. It’s one of many Botox-related license plates he owns, including some more scientific nods like one that says “Snap-25.” That’s a reference to a protein affected by botulinum toxin A, leading to smoother foreheads when used in the right doses.
“Botox is a big component of my life,” Brin told Business Insider.
Brin is one of the scientists who saw Botox through from its early days as a potential treatment for muscle disorders to what it is today — a blockbuster pharmaceutical drug best known for cosmetic uses like smoothing out wrinkles on patients’ faces.
Here’s the story of how a poisonous toxin became a blockbuster treatment for everything from wrinkles to migraines.
-
Business7 days ago
Google Gemini: Everything you need to know about the new generative AI platform
-
Entertainment5 days ago
Hands-on with the Claude AI app: It’s pleasant to use, but janky
-
Business5 days ago
Haun Ventures is riding the bitcoin high
-
Entertainment6 days ago
‘Bridgerton’: Everything you need to remember before Season 3
-
Entertainment3 days ago
Apple Watch Series 9 vs. SE: A smartwatch skeptic tested both for 13 days
-
Entertainment4 days ago
5 essential gadgets for turning your home into a self-care sanctuary
-
Business4 days ago
Apple: pay attention to emerging markets, not falling China sales
-
Business4 days ago
Google dubs Epic’s demands from its antitrust win ‘unnecessary’ and ‘far beyond the scope’ of the verdict